Article
MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?
European journal of internal medicine - 1 Jun 2026
Stea Emma Diletta, Pesce Francesco, Bari Ighli di, Franzin Rossana, Rossini Michele, Simone Simona, Piancone Fausta, Sallustio Fabio, De Palma Arianna, Grignano Maria Antonietta, Pontrelli Paola, Gregorini Marilena, Islami Tefik, Rampino Teresa, Castellano Giuseppe, Gesualdo Loreto
Abstract excerpt
IgA nephropathy (IgAN) is a leading cause of End-Stage Renal Disease, with kidney transplantation as the preferred treatment, although with unpredictable and diverse outcomes. Mannose-binding lectin (MBL), a key component of the lectin pathway (LP), is associated with IgAN, and both excessive and deficient levels may exacerbate the disease. Genetic variants in MBL2 affect MBL serum levels and function,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
